In the world of fundamental analysis, most investors obsess over revenue growth, profit margins, and return ratios. These are important metrics, no doubt. But there is […]
📅 Published April 8, 2026 (Wednesday) The Man Who Turned ₹5,000 Into ₹500+ Crore — Without a Single Blue-Chip Stock While most investors chase Reliance, HDFC […]
📅 Published April 07, 2026 (Tuesday) Why Most Indian Investors Get Valuation Completely Wrong Here is a question that separates serious investors from speculators: if a […]
Titan Biotech (BSE: 524717) has compounded its Earnings Per Share at 28.6% CAGR over 10 years — from ₹0.42 in FY2015 to ₹5.21 in FY2025. This deep-dive case study reveals what EPS growth analysis tells us about business quality and how to use it for intrinsic value estimation.